How to Buy Actinium Pharmaceuticals Stock
Actinium Pharmaceuticals Inc
Actinium Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or adoptive cell therapies.
Actinium Pharmaceuticals stock last closed at $1.15, down 0.86% from the previous day, and has increased 0% in one year. It has overperformed other stocks in the Biotechnology industry by 0.31 percentage points. Actinium Pharmaceuticals stock is currently +11.76% from its 52-week low of $1.03, and -52.28% from its 52-week high of $2.41.
As of Feb 6, 2026, there are 31.2M shares of ATNM outstanding. The market capitalization of ATNM is $35.88M. In the past 24 hours, 78,000 ATNM shares were traded.
How to Buy Actinium Pharmaceuticals Stock
Wondering how to invest in Actinium Pharmaceuticals stock? Here's how.
- Decide where to buy Actinium Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Actinium Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Pick your payment method and add your info.
- Analyze Actinium Pharmaceuticals stock: The Actinium Pharmaceuticals ticker symbol is ATNM. Is Actinium Pharmaceuticals stock a good investment? Should you buy shares of ATNM? How do ATNM's underlying business fundamentals look? Do top analysts think Actinium Pharmaceuticals is a good buy? Why has ATNM's stock price moved recently? (Hint: Our stock market research tools can help you figure out if ATNM is a good stock to buy).
- Execute your ATNM trade: Decide if you will purchase ATNM shares at the current market price or use a limit order to purchase ATNM stock at a given price.
- Keep tabs on your ATNM position: Create a watchlist to the latest updates on your position in Actinium Pharmaceuticals stock.
Step 1: Decide where to buy Actinium Pharmaceuticals stock
You will need a brokerage account in order to access the NYSEMKT market and buy ATNM stock.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal details so you are able to invest in ATNM stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start a new trading account.
- Send your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on stock market apps, you need to deposit funds:
Check out the walkthrough below for more details depositing money into your new investment account.
Step 4: Analyze Actinium Pharmaceuticals stock
Once you have identified the best place to buy Actinium Pharmaceuticals stock, it's crucial to research their stock before you invest, so you truly comprehend the risk as well as the opportunity.
Actinium Pharmaceuticals quick stats
Fundamentals of Actinium Pharmaceuticals
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on ATNM's stock page.
Is ATNM stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ATNM's fair value.
Using relative valuations metrics:
- ATNM could be undervalued based on its P/B ratio of 2.6x, relative to Biotechnology industry P/B ratio of 5.16x
You can do additional valuation analysis on ATNM's stock here.
ATNM Financial Summary
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the ATNM balance sheet.
- There are more short-term assets than short-term liabilities on the ATNM balance sheet.
- ATNM has cash burn of 25042000. It has enough cash and short-term investments to cover this for at least one year.
- ATNM has $53.39M in cash and short term investments. This is enough to cover its annual cash burn of $25.04M.
Failed Financial Due Diligence Checks:
- ATNM profit margin has gone up by 120.69 percentage points in the past year, but the company is still unprofitable.
- Total ATNM debt is higher than 5 years ago, relative to shareholder equity.
- ATNM has a relatively high debt to equity ratio of 3.07.
You can dig deeper into what analysts are forecasting on the Actinium Pharmaceuticals stock forecast page.
ATNM Momentum
ATNM Growth Metrics
Last year, ATNM revenue was $90.00k. In the last four year, ATNM's revenue has gone up by -46.77% per year. This was slower than the Biotechnology industry average of 42.94%.
You can research ATNM's earnings and revenue performance here.
Are ATNM insiders buying or selling the stock?
Over the last year, executives and large shareholders at ATNM have sold more shares than they have bought.
Sandesh Seth, Chief Executive Officer of ATNM, was the latest ATNM insider to sell. They sold $206,739.00 worth of ATNM shares on Aug 18, 2025.
Research more about who owns ATNM shares here.
Can I rely on ATNM as an income stream?
No, Actinium Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about ATNM
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your ATNM trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly fine. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular price limit, use a limit order.
Click the Open Trade button and your broker will place your order.
If you require additional info about investing in stocks on eToro, click the how to video below:
Step 6: Keep tabs on your ATNM position
Now that you own some ATNM shares, you'll want to stay up-to-date on your new investment.
Put ATNM on a watchlist to keep track of your ATNM stock.
ATNM Feed
How to Buy Stock in Actinium Pharmaceuticals
To summarize, here are the 6 steps to buy Actinium Pharmaceuticals stock:
- Decide where to buy Actinium Pharmaceuticals stock
- Create your brokerage account
- Deposit funds into your investment account
- Analyze Actinium Pharmaceuticals stock
- Execute your ATNM trade
- Keep tabs on your ATNM position
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Actinium Pharmaceuticals, create a watchlist today.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.